João Renato Bennini Junior
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
João Renato Bennini Junior has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Luis Otávio Sarian
Department of Gynecology and Obstetrics, Fetal Medicine Program State University of Campinas Campinas Brazil
2 shared publications - Ana Paula de Morais e Oliveira
Universidade Estadual de Campinas
1 shared publication - Carolina de Freitas Alves Amaral-Moreira
Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, Brazil
1 shared publication - Fernanda Garanhani Surita
Universidade Estadual de Campinas
1 shared publication - Geovanna Saboia Veras
Department of Obstetrics and Gynecology The State University of Campinas Campinas SP Brazil
1 shared publication - Isadora Macedo Lins Parentes Fortes
Fetal Medicine Program, Department of Gynecology and Obstetrics, Women's Hospital, University of Campinas, Campinas, SP, Brazil
1 shared publication
Latest Publications
- Open Access
- 8 August 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
Prenatal screening and diagnostic strategies for fetal genetic abnormalities: Comparison of international clinical guidelines
This study compares recommendations from international clinical guidelines regarding prenatal screening and diagnostic testing for fetal genetic abnormalities, including the role of non‐invasive prenatal testing (NIPT), invasive diagnostic procedures, and advanced genomic technologies. An integrative review was conducted in guidelines and consensus statements from international societies to compare recommendations regarding prenatal screening and diagnostic testing for fetal genetic abnormalities, including the role of NIPT, invasive diagnostic procedures, and advanced genomic technologies. A systematic search was conducted in PubMed, Scopus, the Cochrane Library, and EMBASE for guidelines published up to December 2025. Guidelines from major obstetrics and genetics societies were included. Findings were synthesized and compared qualitatively across guidelines. Nine international guidelines were included in the analysis. Most societies recommend offering prenatal screening for aneuploidy to all pregnant women. NIPT was consistently described as the most sensitive screening method for common aneuploidies, although not recommended as a diagnostic test. Invasive procedures, including amniocentesis and chorionic villus sampling, remain the gold standard for diagnostic confirmation. Recommendations regarding advanced genomic testing varied, with chromosomal microarray generally recommended in cases of fetal structural anomalies, while routine prenatal exome sequencing remains limited to selected scenarios. Although international guidelines show broad agreement regarding the importance of prenatal screening and confirmatory diagnostic testing, differences persist in the implementation of screening strategies and the integration of emerging genomic technologies.
- 8 August 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
Open AccessPrenatal screening and diagnostic strategies for fetal genetic abnormalities: Comparison of international clinical guidelines
This study compares recommendations from international clinical guidelines regarding prenatal screening and diagnostic testing for fetal genetic abnormalities, including the role of non‐invasive prenatal testing (NIPT), invasive diagnostic procedures, and advanced genomic technologies. An integrative review was conducted in guidelines and consensus statements from international societies to compare recommendations regarding prenatal screening and diagnostic testing for fetal genetic abnormalities, including the role of NIPT, invasive diagnostic procedures, and advanced genomic technologies. A systematic search was conducted in PubMed, Scopus, the Cochrane Library, and EMBASE for guidelines published up to December 2025. Guidelines from major obstetrics and genetics societies were included. Findings were synthesized and compared qualitatively across guidelines. Nine international guidelines were included in the analysis. Most societies recommend offering prenatal screening for aneuploidy to all pregnant women. NIPT was consistently described as the most sensitive screening method for common aneuploidies, although not recommended as a diagnostic test. Invasive procedures, including amniocentesis and chorionic villus sampling, remain the gold standard for diagnostic confirmation. Recommendations regarding advanced genomic testing varied, with chromosomal microarray generally recommended in cases of fetal structural anomalies, while routine prenatal exome sequencing remains limited to selected scenarios. Although international guidelines show broad agreement regarding the importance of prenatal screening and confirmatory diagnostic testing, differences persist in the implementation of screening strategies and the integration of emerging genomic technologies.
- 30 April 2026
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 67 (6) , 864-868
Antenatal diagnosis of twin anemia–polycythemia sequence: current challenges and need for standardization
- 30 April 2026
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 67 (6) , 864-868
Antenatal diagnosis of twin anemia–polycythemia sequence: current challenges and need for standardization
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Estudos de Psicologia (Campinas)
- Vol. 43
The dilemmas of pregnant women diagnosed with lethal fetal malformation
This study aimed to understand the factors that influenced the decision of pregnant women diagnosed with a fetal malformation incompatible with postnatal life, to either maintain or terminate the pregnancy, as well as to assess the emotional impact of this experience. This qualitative study was conducted with 11 pregnant women at a benchmark public service on fetal medicine. Interviews were carried out to collect sociodemographic and clinical data and trigger questions were audio-recorded. The narratives were analyzed, and categories emerged from them, illustrated by excerpts from the interviews. Waiting for a miracle, the perception of motherhood and values against termination influenced the choice to keep the pregnancy. The lack of hope of having a living child, the belief that termination would bring relief from suffering and the legal right to abortion influenced the choice to terminate. Regardless of the decision, the women’s perplexity at the diagnosis, as well as feelings of guilt, anguish and sadness stand out. Because this type of grief is still rarely acknowledged, it is crucial for healthcare teams to implement humanized and technically competent approaches that support women’s decision-making processes, uphold their rights, and assist them in coping with the grief of their loss.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Estudos de Psicologia (Campinas)
- Vol. 43
Open AccessThe dilemmas of pregnant women diagnosed with lethal fetal malformation
This study aimed to understand the factors that influenced the decision of pregnant women diagnosed with a fetal malformation incompatible with postnatal life, to either maintain or terminate the pregnancy, as well as to assess the emotional impact of this experience. This qualitative study was conducted with 11 pregnant women at a benchmark public service on fetal medicine. Interviews were carried out to collect sociodemographic and clinical data and trigger questions were audio-recorded. The narratives were analyzed, and categories emerged from them, illustrated by excerpts from the interviews. Waiting for a miracle, the perception of motherhood and values against termination influenced the choice to keep the pregnancy. The lack of hope of having a living child, the belief that termination would bring relief from suffering and the legal right to abortion influenced the choice to terminate. Regardless of the decision, the women’s perplexity at the diagnosis, as well as feelings of guilt, anguish and sadness stand out. Because this type of grief is still rarely acknowledged, it is crucial for healthcare teams to implement humanized and technically competent approaches that support women’s decision-making processes, uphold their rights, and assist them in coping with the grief of their loss.
- Open Access
Follow-up of immediate postpartum intrauterine device insertion: a scoping review protocol
Introduction The intrauterine device (IUD) inserted immediately after delivery is a safe and effective measure for preventing unplanned pregnancies. Despite exhibiting a higher expulsion rate compared with later insertions, it proves cost-effective due to the high rate of continuity of the method. There is still a gap in the literature regarding the optimal strategy for monitoring these patients, whether it should be through clinical examination, ultrasound or both. The aim of this review is to map the available evidence regarding the proper clinical and ultrasound follow-up procedures of IUDs inserted immediately post partum. Methods and analysis Using the well-established scoping review methodology outlined by the Joanna Briggs Institute, a five-stage review is outlined: (1) determining the research question, (2) search strategy, (3) inclusion criteria, (4) data extraction and (5) analysis and presentation of the results. The search strategy will be applied to nine databases reflecting empirical and grey literature. A two-step screening process will be used to determine eligibility of articles. To be included in the review, articles must describe how postpartum women (adolescents or adults) who had an IUD inserted immediately after birth (vaginal or caesarean) were followed up. All articles will be independently assessed for eligibility, and data from eligible articles will be extracted and charted using a standardised form. Extracted data will be analysed using narrative and descriptive analyses. Ethics and dissemination Ethics approval is not required. The results will be disseminated to the health science community through professional networks, conference presentations and publication in a scientific journal.
Open AccessFollow-up of immediate postpartum intrauterine device insertion: a scoping review protocol
Introduction The intrauterine device (IUD) inserted immediately after delivery is a safe and effective measure for preventing unplanned pregnancies. Despite exhibiting a higher expulsion rate compared with later insertions, it proves cost-effective due to the high rate of continuity of the method. There is still a gap in the literature regarding the optimal strategy for monitoring these patients, whether it should be through clinical examination, ultrasound or both. The aim of this review is to map the available evidence regarding the proper clinical and ultrasound follow-up procedures of IUDs inserted immediately post partum. Methods and analysis Using the well-established scoping review methodology outlined by the Joanna Briggs Institute, a five-stage review is outlined: (1) determining the research question, (2) search strategy, (3) inclusion criteria, (4) data extraction and (5) analysis and presentation of the results. The search strategy will be applied to nine databases reflecting empirical and grey literature. A two-step screening process will be used to determine eligibility of articles. To be included in the review, articles must describe how postpartum women (adolescents or adults) who had an IUD inserted immediately after birth (vaginal or caesarean) were followed up. All articles will be independently assessed for eligibility, and data from eligible articles will be extracted and charted using a standardised form. Extracted data will be analysed using narrative and descriptive analyses. Ethics and dissemination Ethics approval is not required. The results will be disseminated to the health science community through professional networks, conference presentations and publication in a scientific journal.
- Open Access
- 2 February 2022
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 44 (03) , 304-310
Use of Corticosteroids in Prenatal Treatment of Congenital Pulmonary Adenomatoid Malformation: Integrative Review
Objective To review data on the use of corticosteroids for the treatment of fetuses with high-risk congenital pulmonary adenomatoid malformation (CPAM). Methods Integrative review based on the literature available on MEDLINE and LILACS, including articles published until November, 2020. Results The initial search resulted in 87 articles, 4 of which were selected for analysis, with all of them being retrospective descriptive observational studies. In the group of fetuses that received only a single corticosteroid cycle, the hydrops resolution rate was 70%, and the survival rate was 83.8%. In fetuses treated with 2 or more cycles of corticosteroids, there was an improvement in the condition of hydrops or edema in a single body compartment in 47%, and survival of 81.8% of the fetuses. Conclusion The use of corticosteroids for the prenatal treatment of high-risk CPAM appears to be associated with an improvement in perinatal outcomes.
- 2 February 2022
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 44 (03) , 304-310
Open AccessUse of Corticosteroids in Prenatal Treatment of Congenital Pulmonary Adenomatoid Malformation: Integrative Review
Objective To review data on the use of corticosteroids for the treatment of fetuses with high-risk congenital pulmonary adenomatoid malformation (CPAM). Methods Integrative review based on the literature available on MEDLINE and LILACS, including articles published until November, 2020. Results The initial search resulted in 87 articles, 4 of which were selected for analysis, with all of them being retrospective descriptive observational studies. In the group of fetuses that received only a single corticosteroid cycle, the hydrops resolution rate was 70%, and the survival rate was 83.8%. In fetuses treated with 2 or more cycles of corticosteroids, there was an improvement in the condition of hydrops or edema in a single body compartment in 47%, and survival of 81.8% of the fetuses. Conclusion The use of corticosteroids for the prenatal treatment of high-risk CPAM appears to be associated with an improvement in perinatal outcomes.
- 18 January 2022
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 59 (4) , 428-436
Diagnosis of placenta accreta spectrum in high‐risk women using ultrasonography or magnetic resonance imaging: systematic review and meta‐analysis
Objectives: To perform a systematic review and meta‐analysis of the diagnostic test accuracy of ultrasound and magnetic resonance imaging (MRI) and compare the performance of the two modalities in the diagnosis of placenta accreta spectrum (PAS).Methods: This was a systematic review conducted following the Cochrane Diagnostic Test Accuracy Reviews guideline. A literature search was performed in five databases: PubMed, EMBASE, PMC, The Cochrane Library and BVS‐Bireme between 27 July and 4 August 2020. The search was updated on 18 August 2021. We included observational studies evaluating diagnostic accuracy in women with risk factors for PAS who had undergone both ultrasound and MRI examinations, published in English between 2011 and 2021. Quality Assessment of Diagnostic Accuracy Studies‐2 was used to evaluate the quality of the studies. Forest plots for sensitivity and specificity with 95% CIs and receiver‐operating‐characteristics curves for ultrasound and MRI were constructed.Results: The literature search identified 266 studies. After reviewing the titles and abstracts of the articles, 51 were selected for full‐text review and 17 studies including 1301 women with MRI and ultrasound data available were selected for the meta‐analysis. The study population included 457 cases with PAS diagnosed using the gold standard method (intraoperative or histopathological analysis). The overall quality of the evaluated studies was considered satisfactory according to QUADAS‐2. The meta‐analysis revealed a sensitivity of 0.833 (95% CI, 0.776–0.878) and specificity of 0.834 (95% CI, 0.746–0.897) for ultrasound. For MRI, sensitivity was 0.838 (95% CI, 0.786–0.879) and specificity was 0.831 (95% CI, 0.770–0.878). There was no statistically significant difference between the two modalities. The Cochran's Q values indicated a high level of heterogeneity of sensitivity and specificity of ultrasound and MRI across studies.Conclusions: Ultrasound and MRI have similar accuracy in the diagnosis of PAS. These results suggest that, in a setting with a high prevalence of risk factors, the choice of imaging modality for initial screening for PAS should depend on the availability of equipment and the examiner's expertise. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
- 18 January 2022
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 59 (4) , 428-436
Diagnosis of placenta accreta spectrum in high‐risk women using ultrasonography or magnetic resonance imaging: systematic review and meta‐analysis
Objectives: To perform a systematic review and meta‐analysis of the diagnostic test accuracy of ultrasound and magnetic resonance imaging (MRI) and compare the performance of the two modalities in the diagnosis of placenta accreta spectrum (PAS).Methods: This was a systematic review conducted following the Cochrane Diagnostic Test Accuracy Reviews guideline. A literature search was performed in five databases: PubMed, EMBASE, PMC, The Cochrane Library and BVS‐Bireme between 27 July and 4 August 2020. The search was updated on 18 August 2021. We included observational studies evaluating diagnostic accuracy in women with risk factors for PAS who had undergone both ultrasound and MRI examinations, published in English between 2011 and 2021. Quality Assessment of Diagnostic Accuracy Studies‐2 was used to evaluate the quality of the studies. Forest plots for sensitivity and specificity with 95% CIs and receiver‐operating‐characteristics curves for ultrasound and MRI were constructed.Results: The literature search identified 266 studies. After reviewing the titles and abstracts of the articles, 51 were selected for full‐text review and 17 studies including 1301 women with MRI and ultrasound data available were selected for the meta‐analysis. The study population included 457 cases with PAS diagnosed using the gold standard method (intraoperative or histopathological analysis). The overall quality of the evaluated studies was considered satisfactory according to QUADAS‐2. The meta‐analysis revealed a sensitivity of 0.833 (95% CI, 0.776–0.878) and specificity of 0.834 (95% CI, 0.746–0.897) for ultrasound. For MRI, sensitivity was 0.838 (95% CI, 0.786–0.879) and specificity was 0.831 (95% CI, 0.770–0.878). There was no statistically significant difference between the two modalities. The Cochran's Q values indicated a high level of heterogeneity of sensitivity and specificity of ultrasound and MRI across studies.Conclusions: Ultrasound and MRI have similar accuracy in the diagnosis of PAS. These results suggest that, in a setting with a high prevalence of risk factors, the choice of imaging modality for initial screening for PAS should depend on the availability of equipment and the examiner's expertise. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.